Literature DB >> 7553642

Microdissection based cloning of a translocation breakpoint in a human malignant melanoma.

J Zhang1, P Cui, A A Glatfelter, L M Cummings, P S Meltzer, J M Trent.   

Abstract

Chromosome translocations in human malignancies have identified the genomic location of several important growth-regulatory sequences (e.g., cellular oncogenes and suppressor genes). Melanomas are characterized by recurring chromosome alterations, including deletion or translocations of the long arm of chromosome 6 (6q). This report details our efforts to clone the t(1;6)(q21;q14) breakpoint in a malignant melanoma to further our understanding of the biology of these tumors. The strategy utilized combined microdissection of the translocation chromosome, development and characterization of a DNA microclone library, isolation of cosmids and YACs from the breakpoint region, ordering of clones by two-color metaphase/interphase fluorescence in situ hybridization, and finally, identification of a YAC spanning the translocation breakpoint. By analogy to other tumor systems, molecular examination of the chromosome 6 breakpoint may provide insight into the pathobiology of this important neoplasm.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553642

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  2 in total

1.  CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma.

Authors:  Vladislava O Melnikova; Andrey S Dobroff; Maya Zigler; Gabriel J Villares; Russell R Braeuer; Hua Wang; Li Huang; Menashe Bar-Eli
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

2.  Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.

Authors:  S Huang; D Jean; M Luca; M A Tainsky; M Bar-Eli
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.